Medication Sales and Syndromic Surveillance, Figure 2

Volume 12, Number 3, March 2006

Medication Sales and Syndromic Surveillance, France

Elisabeta Vergu,*†‡ Rebecca F. Grais,*† Hélène Sarter,*† Jean-Paul Fagot,*† Bruno Lambert,§ Alain-Jacques Valleron,*†¶ and Antoine Flahault*†#
*Institut National de la Santé et de la Recherche Medicale Unité, Paris, France; †Université Pierre et Marie Curie, Paris, France; ‡Institut National de la Recherche Agronomique MIA, Jouy-en-Josas, France; §IMS FRANCE, Puteaux, France; ¶Hôpital Saint-Antoine, Paris, France; and #Hôpital Tenon, Paris, France


	Back to article
	Figure 2. Model construction for national influenzalike illness (ILI) incidence forecasting 1, 2, and 3 weeks ahead for the training dataset (week 36 of year 2000 to week 38 of year 2003) by using a jackknife reestimation procedure (95% confidence intervals [CI] for estimations are given). Forecasted incidence is per 100,000.

	EID Home \| Top of Page \| Ahead-of-Print \| Past Issues \| Suggested Citation \| EID Search \| Contact Us \| Accessibility \| Privacy Policy Notice \| CDC Home \| CDC Search \| Health Topics A-Z

	This page last reviewed February 21, 2006

	Emerging Infectious Diseases Journal National Center for Infectious Diseases Centers for Disease Control and Prevention